Literature DB >> 14716682

Sequence-specific gene silencing in murine muscle induced by electroporation-mediated transfer of short interfering RNA.

Tsunao Kishida1, Hidetsugu Asada, Satoshi Gojo, Suzuyo Ohashi, Masaharu Shin-Ya, Kakei Yasutomi, Ryu Terauchi, Kenji A Takahashi, Toshikazu Kubo, Jiro Imanishi, Osam Mazda.   

Abstract

BACKGROUND: Post-genomic biomedical research requires efficient techniques for functional analyses of poorly characterized genes in living organisms. Sequence-specific gene silencing in mammalian organs may provide valuable information on the physiological and pathological roles of predicted genes in mammalian systems. Here, we attempted targeted gene knockdown in vivo in murine skeletal muscle through the electroporation-mediated transfer of short interfering RNA (siRNA).
METHODS: siRNA duplexes corresponding to the firefly luciferase (Luc), green fluorescent protein (GFP), or glyceraldehyde-3-phosphate dehydrogenase (GAPD) genes were delivered by electroporation into the tibial muscle of normal or enhanced GFP (EGFP) transgenic mice. Plasmid vectors carrying the Luc, hRluc or beta-galactosidase (beta-gal) reporter genes were also delivered. The Luc and hRluc activities in the muscle lysates were assayed. The EGFP and GAPD expression was detected by fluorescence microscopic observation and RT-PCR, respectively.
RESULTS: When Luc-specific siRNA was co-delivered with the Luc expression vector into the tibial muscle, the reporter gene expression was markedly suppressed (less than 1% of the control level) for 5 days. As little as 0.05 micro g of siRNA almost completely blocked the reporter gene expression from 10 micro g of the plasmid. To examine whether siRNA can also suppress expression of an endogenous gene, transgenic mice carrying the EGFP gene received intramuscular transfection of a mixture of beta-gal plasmid and GFP-specific siRNA. beta-Gal-positive cells failed to express detectable levels of EGFP, while EGFP expression was not inhibited in control mice that received nonspecific siRNA. Expression of GAPD was also suppressed by the specific siRNA.
CONCLUSIONS: The present system may provide a useful means of phenotypic analysis of genetic information in mammalian organs for basic research as well as therapeutic molecular targeting in the post-genomic era. Copyright 2003 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14716682     DOI: 10.1002/jgm.456

Source DB:  PubMed          Journal:  J Gene Med        ISSN: 1099-498X            Impact factor:   4.565


  14 in total

Review 1.  Nonviral delivery of synthetic siRNAs in vivo.

Authors:  Saghir Akhtar; Ibrahim F Benter
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

2.  Direct visualization at the single-cell level of siRNA electrotransfer into cancer cells.

Authors:  A Paganin-Gioanni; E Bellard; J M Escoffre; M P Rols; J Teissié; M Golzio
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-13       Impact factor: 11.205

Review 3.  The role of non-coding RNAs in neuroprotection and angiogenesis following ischemic stroke.

Authors:  Elaheh Heydari; Masoumeh Alishahi; Farhoodeh Ghaedrahmati; William Winlow; Seyed Esmaeil Khoshnam; Amir Anbiyaiee
Journal:  Metab Brain Dis       Date:  2019-08-24       Impact factor: 3.584

4.  Sustained long-term RNA interference in nucleus pulposus cells in vivo mediated by unmodified small interfering RNA.

Authors:  Teppei Suzuki; Kotaro Nishida; Kenichiro Kakutani; Koichiro Maeno; Takashi Yurube; Toru Takada; Masahiro Kurosaka; Minoru Doita
Journal:  Eur Spine J       Date:  2009-01-14       Impact factor: 3.134

5.  Novel dual inhibitory function aptamer-siRNA delivery system for HIV-1 therapy.

Authors:  Jiehua Zhou; Haitang Li; Shirley Li; John Zaia; John J Rossi
Journal:  Mol Ther       Date:  2008-05-06       Impact factor: 11.454

Review 6.  Nonviral methods for siRNA delivery.

Authors:  Kun Gao; Leaf Huang
Journal:  Mol Pharm       Date:  2009 May-Jun       Impact factor: 4.939

Review 7.  Emerging Roles of microRNAs in Ischemic Stroke: As Possible Therapeutic Agents.

Authors:  Seyed Esmaeil Khoshnam; William Winlow; Yaghoob Farbood; Hadi Fathi Moghaddam; Maryam Farzaneh
Journal:  J Stroke       Date:  2017-05-08       Impact factor: 6.967

8.  Tracking in vitro and in vivo siRNA electrotransfer in tumor cells.

Authors:  Aurelie Paganin-Gioanni; Elisabeth Bellard; Bettina Couderc; Justin Teissié; Muriel Golzio
Journal:  J RNAi Gene Silencing       Date:  2008-05-27

9.  Delivery of RNAi-Based Oligonucleotides by Electropermeabilization.

Authors:  Sophie Chabot; Sandrine Pelofy; Justin Teissié; Muriel Golzio
Journal:  Pharmaceuticals (Basel)       Date:  2013-04-10

10.  Electroporation Enhanced Effect of Dystrophin Splice Switching PNA Oligomers in Normal and Dystrophic Muscle.

Authors:  Camilla Brolin; Takehiko Shiraishi; Pernille Hojman; Thomas O Krag; Peter E Nielsen; Julie Gehl
Journal:  Mol Ther Nucleic Acids       Date:  2015-12-01       Impact factor: 10.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.